Registering a CAGR of 8.4%, the global choline supplement market size is projected to increase from US$ 612.0 million in 2024 to US$ 1,367.9 million by 2034. Factors like escalating awareness of the importance of choline on human health and growing emphasis on preventive healthcare will fuel this growth.
Demand remains particularly high for choline bitartrate supplements, rising at 8.2% CAGR. This can be attributed to better absorption, stability, and cost-effectiveness of choline bitartrate. The target segment is poised to account for a value share of 42.0% by 2034.
| Attributes | Key Insights |
|---|---|
| Market Size in 2024 | US$ 612.0 million |
| Market Value in 2034 | US$ 1,367.9 million |
| CAGR (2024 to2034) | 8.4% |
Choline supplements are witnessing strong demand, and the trend is set to persist throughout the forecast period. This is attributable to rising consumer preference for choline supplements due to their potential health benefits.
Choline products have the ability to improve brain, heart, and liver health. These supplements provide choline, an essential nutrient that plays a key role in many bodily functions, including cell membrane health, brain function, and liver health.
Growing consumer interest in brain health supplements and other dietary formulations is set to boost sales of choline supplements. Subsequently, escalating demand for choline supplements during pregnancy to ensure proper placental function, brain development, and fetal growth will benefit the market.
It has been observed that choline deficiency during pregnancy can lead to complications like preterm birth and preeclampsia. To counter this, pregnant women are consuming choline products, thereby boosting market growth.
Choline deficiency is also believed to cause fatty liver disease, also known as hepatosteatosis. This is prompting people to invest in choline supplement products, resulting in higher sales.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising consumer focus on brain health and wellness is fueling the demand for choline supplements. Increasing interest in non-GMO specialty supplements to avoid side effects of GMO supplements will boost sales growth.
Gluten-free supplements are gaining traction in the market due to the increased prevalence of gluten intolerance. Subsequently, clean-label choline products derived from natural sources, such as potatoes, peanuts, and sunflower seeds, are gaining popularity.
Several food and beverage manufacturers are incorporating choline into their products to meet growing consumer demand for healthier options. Thus, surging popularity of fortified foods and beverages will create growth opportunities for the choline product market.
The rising geriatric population, coupled with a surge in health problems like dementia and cognitive decline, will benefit the target market. Similarly, rise in research and scientific studies aimed at exploring the role and health benefits of choline will open new growth opportunities.
Principal Consultant
Global sales of supplements grew at a CAGR of 5.1% from 2019 to 2023. However, a robust CAGR of 8.4% has been predicted for the global choline product industry in the forecast period, displaying a 3.3% spike from the historical growth rate.
Increasing consumer awareness about the health benefits of choline and changing dietary preferences are anticipated to propel global demand for choline supplements. Another prominent growth-shaping factor is the rising incidence of liver diseases like non-alcoholic fatty liver disease (NAFLD).
On the other hand, factors such as low awareness of choline and its benefits, especially in developing and underdeveloped regions, and regulatory changes will limit market growth. To cope with these challenges, key supplement manufacturers are focusing on educating people about the importance of choline on human health.
The table below shows the predicted CAGR of the leading nations. Australia and Germany are set to witness high supplement consumption, recording CAGRs of 7.3% and 6.7%, respectively, through 2034. This can be attributed to rising applications of choline in prenatal nutrition as well as sports nutrition.
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 4.8% |
| Germany | 6.7% |
| India | 5.8% |
| Australia | 7.3% |
The United States choline supplement market is poised to attain a valuation of around US$ 277.5 million in 2034. It will register steady growth, with sales of rising at 4.8% CAGR throughout the forecast period.
Multiple factors are spurring growth of the choline product industry in the United States. These include growing demand for brain health supplements, a spike in liver and brain diseases, and increasing attention toward fitness and disease prevention.
There is a surging demand for supplements that enhance brain health across the United States, spurred by growing geriatric population and surge in neurological disorders like Alzheimer’s disease. This, in turn, is set to positively impact supplement sales in the nation.
The adoption of a hectic lifestyle is another key factor propelling demand for choline supplements. Similarly, escalating demand for choline-fortified infant formulas will improve the United States market share through 2034.
The choline supplement market in India is anticipated to grow at 5.8% CAGR throughout the forecast period, totaling a valuation of around US$ 84.7 million by 2034. This can be attributed to factors like escalating awareness of the choline and surging demand for fortified foods.
The consumption of supplements is increasing steadily in India due to changing lifestyles and growing preference for healthy supplements. The progressive aging of the Indian population and consequential growth of specific health needs will boost growth of the choline supplement market.
Consumers across India are becoming more health conscious, urging them to seek supplements that can improve their health and well-being. This will uplift demand for choline products in the nation through 2034 and beyond.
Leading players operating in India are educating people about the importance of choline on brain and liver health through advertisements and other promotional activities. This is anticipated to improve choline product consumption in the nation.
Germany’s choline supplement market value is set to total around US$ 155.8 million by 2034, registering a CAGR of 6.7% throughout the projection period. This can be attributed to factors such as rising incidence of cardiovascular disease and growing emphasis on preventive healthcare.
There is a sharp increase in food supplement launches and consumption amid rising health awareness. According to the German Federal Office of Consumer Protection of Food Safety, around 8,000 new food supplement products were registered in Germany in 2018.
Preventative healthcare trends are gaining momentum across Germany due to rising diseases related to heart, brain, and liver. This, in turn, is projected to fuel demand for choline products as they are essential for enhancing brain and liver health.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below sheds some light on leading segments along with their projected growth rates. Companies can use this information to invest in popular products and forms to solidify their positions in the global choline product industry.
By ingredient type, the choline bitartrate segment is poised to grow at 8.2% CAGR through 2034. Based on form, choline capsules segment will probably account for a revenue share of 67.5% by 2034. By claim, the non-GMO is forecast to record a 5.7% CAGR from 2024 to 2034.
| Top Segment (Ingredient Type) | Choline Bitartrate |
|---|---|
| CAGR (2024 to 2034) | 8.2% |
As per the latest analysis, demand for choline bitartrate-based supplements is forecast to grow at a higher CAGR of 8.2% during the projection period. The target segment will generate a total revenue of around US$ 505.7 million by 2034.
Higher bioavailability, affordability, and lower hygroscopicity of choline bitartrate are key factors behind its rising prominence in the market. Similarly, growing prevalence of neurological disorders and cardiovascular diseases is anticipated to boost segment growth.
Choline bitartrate is the most popular form of choline used in dietary supplementation. This can be attributed to its higher bioavailability, cost-effectiveness, and other advantages. It is mostly used to enhance memory and cognitive function.
Just like B vitamins, choline bitartrate plays a key role in maintaining energy levels, improving metabolism, and enhancing brain function. As a result, it is widely used in dietary supplements to help people with choline and vitamin deficiency.
Choline deficiency causes muscle and liver damage. In order to counter this and manage all problems related to choline deficiency, people consume products, especially choline bitartrate supplements. This will continue to boost growth of the target segment through 2034.
| Top Segment (Form) | Capsule |
|---|---|
| CAGR (2024 to 2034) | 6.5% |
Choline capsules are anticipated to remain the most popular form among consumers, with their consumption rising at a CAGR of 6.7% during the assessment period. Revenue generated by the choline capsules segment will total around US$ 922.7 million in 2034. This can be attributed to the expediency and adaptability of choline capsules.
Choline capsules offer longer shelf life and stability. As a result, they are gaining wider popularity among people with choline deficiency or people looking to enhance their brain and body functions. The adaptability of capsule forms allows manufacturers to create easily replaceable and accurately measured products, thereby helping them to cater to the growing trend of on-the-go and portion-controlled consumption.
Choline powder and liquid supplements can taste bitter and be difficult to swallow. This also encourages people to opt for choline capsules as they are easy to swallow while masking off the unpleasant taste.
| Top Segment (Claim) | Non-GMO |
|---|---|
| CAGR (2024 to 2034) | 5.7% |
The latest analysis estimates non-GMO segment to thrive at 5.7% CAGR through 2034, totaling a valuation of US$ 858.4 million in 2034. It will retain its market dominance, holding a prominent share of 62.8% by 2034. This is attributable to growing consumer preference for non-GMO dietary supplements.
Many consumers consider Non-GMO supplements more natural and safer than GMO ones. As a result, their demand is escalating steadily, and the trend will persist throughout the assessment period.
Factors such as changing lifestyles, increasing aging populations, and growing health problems are anticipated to further boost segment growth. Non-GMO choline products offer multiple health benefits, such as improving brain, heart, and liver health.
Leading manufacturers of supplements are focusing on developing novel solutions in various forms for targeted individuals seeking cognitive enhancement and other benefits. They are marketing their supplements to people interested in health and wellness.
Several players are using celebrity endorsements and social media platforms to promote their products and increase their customer base. Other key market penetration strategies for choline supplement players include partnerships, acquisitions, mergers, distribution agreements, and collaborations.
Recent Developments in the Choline Product Market:
| Attribute | Details |
|---|---|
| Market Size in 2024 | US$ 612.0 million |
| Market Forecast Value in 2034 | US$ 1,367.9 million |
| Global Growth Rate (2024 to 2034) | 8.4% CAGR |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2024 |
| Market Analysis | Volume (MT) and Value (US$ million) |
| Key Regions Covered | Latin America; North America; Europe; East Asia; Middle East & Africa and Oceania; and South Asia |
| Key Countries Covered | United States, Mexico, Canada, Brazil, Chile, Peru, Italy, Argentina, Spain, France, the United Kingdom, Germany, the Netherlands, Belgium, Russia, the Nordic region, Poland, Japan, India, South Korea, China, Malaysia, Thailand, Singapore, Australia, Gulf Cooperation Council countries, Indonesia, New Zealand, Central Africa, and South Africa |
| Key Market Segments Covered | Ingredient Type, Claim, Sales Channel, Form, and Region |
| Key Companies Profiled | NOW Foods; Country Life Vitamins; Nested Naturals; Spring Valley; Solgar (Nestlé); Vitacost; PERQUE Integrative Health; Bestvite; Vitality Nutritionals; UMZU; NusaPure; Nature's Way Products; Country Life Vitamins; The Vitamin Shoppe; Standard Process; Metabolics; Jarrow Formulas; Solaray |
The global market value is set to total US$ 612.0 million in 2024.
The global market size is forecast to reach US$ 1,367.9 million by 2034.
Global demand is predicted to rise at 8.4% CAGR through 2034.
NOW Foods, Nature's Way, Products, Nested Naturals, Spring Valley, and Solgar (Nestlé).
Choline bitartrate and phosphatidylcholine citicoline are best forms of choline to take.
Yes, these supplements are widely available.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition 3. Market Dynamics 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends By Region 3.5. Forecast Factors - Relevance & Impact 3.6. Regulations and Policies 3.7. Impact of the Crisis (COVID) 4. Global Market - Pricing Analysis 4.1. Price Point Assessment By Region 4.1.1. Manufacturer Level Pricing 4.1.2. Distributor Level Pricing 4.1.3. Retail Level Pricing 4.2. Price Point Assessment By Ingredients Type 4.3. Price Forecast till 2034 5. Value Chain Analysis 5.1. Operating margins at each node of supply chain 5.2. List of Active Market Participants 6. Global Market Size in Value (US$ million) and Volume (units) Analysis 2019 to 2023 and Forecast, 2024 to 2034 6.1. Historical Market Size in Value (US$ million) and Volume (units) Analysis, 2019 to 2023 6.2. Current and Future Market Size in Value (US$ million) and Volume (units) Analysis, 2024 to 2034 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Ingredients Type 7.1. Introduction / Key Findings 7.2. Historical Market Size in Value (US$ million) and Volume (units) Analysis By Ingredients Type, 2019 to 2023 7.3. Current and Future Market Size in Value (US$ million) and Volume (units) Analysis and Forecast By Ingredients Type, 2024 to 2034 7.3.1. Choline Bitartrate 7.3.2. Phosphatidylcholine 7.3.3. Citicoline 7.3.4. Alpha-GPC 7.3.5. Choline Chloride 7.4. Market Attractiveness Analysis By Ingredients Type 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Claim 8.1. Introduction / Key Findings 8.2. Historical Market Size in Value (US$ million) and Volume (units) Analysis By Claim, 2019 to 2023 8.3. Current and Future Market Size in Value (US$ million) and Volume (units) Analysis and Forecast By Claim, 2024 to 2034 8.3.1. Non-GMO 8.3.2. GMO 8.3.3. Vegan 8.3.4. Gluten Free 8.4. Market Attractiveness Analysis By Claim 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sales Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size in Value (US$ million) and Volume (units) Analysis By Sales Channel, 2019 to 2023 9.3. Current and Future Market Size in Value (US$ million) and Volume (units) Analysis and Forecast By Sales Channel, 2024 to 2034 9.3.1. Store-based Retailing 9.3.1.1. Hypermarkets/Supermarkets 9.3.1.2. Conventional Stores 9.3.1.3. Drug Stores & Pharmacies 9.3.1.4. Other Retailers 9.3.2. Online Retailing 9.4. Market Attractiveness Analysis By Sales Channel 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Form 10.1. Introduction / Key Findings 10.2. Historical Market Size in Value (US$ million) and Volume (units) Analysis By Form, 2019 to 2023 10.3. Current and Future Market Size in Value (US$ million) and Volume (units) Analysis and Forecast By Form, 2024 to 2034 10.3.1. Capsule 10.3.2. Powders 10.3.3. Liquid 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 11.1. Introduction 11.2. Historical Market Size in Value (US$ million) and Volume (units) Analysis By Region, 2019 to 2023 11.3. Current Market Size in Value (US$ million) and Volume (units) Analysis and Forecast By Region, 2024 to 2034 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. Middle East & Africa 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 12.1. Introduction 12.2. Historical Market Size (US$ million) and Volume(units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.3. Market Size (US$ million) and Volume(units) Forecast By Market Taxonomy, 2024 to 2034 12.3.1. By Country 12.3.1.1. United States 12.3.1.2. Canada 12.3.2. By Ingredients Type 12.3.3. By Claim 12.3.4. By Sales Channel 12.3.5. By Form 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Ingredients Type 12.4.3. By Claim 12.4.4. By Sales Channel 12.4.5. By Form 12.5. Key takeaways 13. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 13.1. Introduction 13.2. Historical Market Size (US$ million) and Volume(units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.3. Market Size (US$ million) and Volume (units) Forecast By Market Taxonomy, 2024 to 2034 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Ingredients Type 13.3.3. By Claim 13.3.4. By Sales Channel 13.3.5. By Form 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Ingredients Type 13.4.3. By Claim 13.4.4. By Sales Channel 13.4.5. By Form 13.5. Key takeaways 14. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ million) and Volume(units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.3. Market Size (US$ million) and Volume(units) Forecast By Market Taxonomy, 2024 to 2034 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. United Kingdom 14.3.1.3. France 14.3.1.4. Italy 14.3.1.5. Spain 14.3.1.6. BENELUX 14.3.1.7. Nordic 14.3.1.8. Russia 14.3.1.9. Poland 14.3.1.10. Rest of Europe 14.3.2. By Ingredients Type 14.3.3. By Claim 14.3.4. By Sales Channel 14.3.5. By Form 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Ingredients Type 14.4.3. By Claim 14.4.4. By Sales Channel 14.4.5. By Form 14.5. Key takeaways 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ million) and Volume(units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.3. Market Size (US$ million) and Volume(units) Forecast By Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Ingredients Type 15.3.3. By Claim 15.3.4. By Sales Channel 15.3.5. By Form 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Ingredients Type 15.4.3. By Claim 15.4.4. By Sales Channel 15.4.5. By Form 15.5. Key takeaways 16. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ million) and Volume(units) Trend Analysis By Market Taxonomy, 2019 to 2023 16.3. Market Size (US$ million) and Volume(units) Forecast By Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Malaysia 16.3.1.4. Indonesia 16.3.1.5. Vietnam 16.3.1.6. Philippines 16.3.1.7. Singapore 16.3.1.8. Rest of South Asia 16.3.2. By Ingredients Type 16.3.3. By Claim 16.3.4. By Sales Channel 16.3.5. By Form 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Ingredients Type 16.4.3. By Claim 16.4.4. By Sales Channel 16.4.5. By Form 16.5. Key takeaways 17. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ million) and Volume(units) Trend Analysis By Market Taxonomy, 2019 to 2023 17.3. Market Size (US$ million) and Volume(units) Forecast By Market Taxonomy, 2024 to 2034 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Ingredients Type 17.3.3. By Claim 17.3.4. By Sales Channel 17.3.5. By Form 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Ingredients Type 17.4.3. By Claim 17.4.4. By Sales Channel 17.4.5. By Form 17.5. Key takeaways 18. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.2. Historical Market Size (US$ million) and Volume(units) Trend Analysis By Market Taxonomy, 2019 to 2023 18.3. Market Size (US$ million) and Volume(units) Forecast By Market Taxonomy, 2024 to 2034 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Türkiye 18.3.1.3. Egypt 18.3.1.4. South Africa 18.3.1.5. Rest of Middle East & Africa 18.3.2. By Ingredients Type 18.3.3. By Claim 18.3.4. By Sales Channel 18.3.5. By Form 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Ingredients Type 18.4.3. By Claim 18.4.4. By Sales Channel 18.4.5. By Form 18.5. Key takeaways 19. Country-level Market Analysis, 2024 19.1. United States Market Analysis 19.1.1. By Ingredients Type 19.1.2. By Claim 19.1.3. By Sales Channel 19.1.4. By Form 19.2. Canada Market Analysis 19.2.1. By Ingredients Type 19.2.2. By Claim 19.2.3. By Sales Channel 19.2.4. By Form 19.3. Brazil Market Analysis 19.3.1. By Ingredients Type 19.3.2. By Claim 19.3.3. By Sales Channel 19.3.4. By Form 19.4. Mexico Market Analysis 19.4.1. By Ingredients Type 19.4.2. By Claim 19.4.3. By Sales Channel 19.4.4. By Form 19.5. Argentina Market Analysis 19.5.1. By Ingredients Type 19.5.2. By Claim 19.5.3. By Sales Channel 19.5.4. By Form 19.6. Germany Market Analysis 19.6.1. By Ingredients Type 19.6.2. By Claim 19.6.3. By Sales Channel 19.6.4. By Form 19.7. United Kingdom Market Analysis 19.7.1. By Ingredients Type 19.7.2. By Claim 19.7.3. By Sales Channel 19.7.4. By Form 19.8. France Market Analysis 19.8.1. By Ingredients Type 19.8.2. By Claim 19.8.3. By Sales Channel 19.8.4. By Form 19.9. Italy Market Analysis 19.9.1. By Ingredients Type 19.9.2. By Claim 19.9.3. By Sales Channel 19.9.4. By Form 19.10. Spain Market Analysis 19.10.1. By Ingredients Type 19.10.2. By Claim 19.10.3. By Sales Channel 19.10.4. By Form 19.11. BENELUX Market Analysis 19.11.1. By Ingredients Type 19.11.2. By Claim 19.11.3. By Sales Channel 19.11.4. By Form 19.12. Nordic Market Analysis 19.12.1. By Ingredients Type 19.12.2. By Claim 19.12.3. By Sales Channel 19.12.4. By Form 19.13. Russia Region Market Analysis 19.13.1. By Ingredients Type 19.13.2. By Claim 19.13.3. By Sales Channel 19.13.4. By Form 19.14. Poland Market Analysis 19.14.1. By Ingredients Type 19.14.2. By Claim 19.14.3. By Sales Channel 19.14.4. By Form 19.15. China Market Analysis 19.15.1. By Ingredients Type 19.15.2. By Claim 19.15.3. By Sales Channel 19.15.4. By Form 19.16. Japan Market Analysis 19.16.1. By Ingredients Type 19.16.2. By Claim 19.16.3. By Sales Channel 19.16.4. By Form 19.17. South Korea Market Analysis 19.17.1. By Ingredients Type 19.17.2. By Claim 19.17.3. By Sales Channel 19.17.4. By Form 19.18. India Market Analysis 19.18.1. By Ingredients Type 19.18.2. By Claim 19.18.3. By Sales Channel 19.18.4. By Form 19.19. Thailand Market Analysis 19.19.1. By Ingredients Type 19.19.2. By Claim 19.19.3. By Sales Channel 19.19.4. By Form 19.20. Malaysia Market Analysis 19.20.1. By Ingredients Type 19.20.2. By Claim 19.20.3. By Sales Channel 19.20.4. By Form 19.21. Indonesia Market Analysis 19.21.1. By Ingredients Type 19.21.2. By Claim 19.21.3. By Sales Channel 19.21.4. By Form 19.22. Vietnam Market Analysis 19.22.1. By Ingredients Type 19.22.2. By Claim 19.22.3. By Sales Channel 19.22.4. By Form 19.23. Philippines Market Analysis 19.23.1. By Ingredients Type 19.23.2. By Claim 19.23.3. By Sales Channel 19.23.4. By Form 19.24. Singapore Market Analysis 19.24.1. By Ingredients Type 19.24.2. By Claim 19.24.3. By Sales Channel 19.24.4. By Form 19.25. Australia Market Analysis 19.25.1. By Ingredients Type 19.25.2. By Claim 19.25.3. By Sales Channel 19.25.4. By Form 19.26. New Zealand Market Analysis 19.26.1. By Ingredients Type 19.26.2. By Claim 19.26.3. By Sales Channel 19.26.4. By Form 19.27. GCC Countries Market Analysis 19.27.1. By Ingredients Type 19.27.2. By Claim 19.27.3. By Sales Channel 19.27.4. By Form 19.28. Türkiye Market Analysis 19.28.1. By Ingredients Type 19.28.2. By Claim 19.28.3. By Sales Channel 19.28.4. By Form 19.29. Egypt Market Analysis 19.29.1. By Ingredients Type 19.29.2. By Claim 19.29.3. By Sales Channel 19.29.4. By Form 19.30. South Africa Market Analysis 19.30.1. By Ingredients Type 19.30.2. By Claim 19.30.3. By Sales Channel 19.30.4. By Form 20. Market Structure Analysis 20.1. Global Market Competition - a Dashboard View 20.2. Industry Structure Analysis 20.2.1. % tier 1 market players 20.2.2. % tier 2 market players 20.2.3. % tier 3 market players 20.3. Global Market Company Share Analysis 20.3.1. For Tier 1 Market Players, 2023 20.3.2. Company Market Share Analysis of Top Players, By Region 20.4. Key Participants Market Presence (Intensity Mapping) By Region 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep Dive 21.3.1. NOW Foods 21.3.1.1. Product Portfolio 21.3.1.2. Product Claim 21.3.1.3. Revenue By Market Segments 21.3.1.4. Sales Footprint 21.3.1.5. Strategy Overview 21.3.1.5.1. Marketing Strategy 21.3.1.5.2. Product Strategy 21.3.1.5.3. Channel Strategy 21.3.1.6. SWOT Analysis 21.3.2. Nature's Way Products 21.3.3. Nested Naturals 21.3.4. Spring Valley 21.3.5. Solgar(Nestlé) 21.3.6. Vitacost 21.3.7. PERQUE Integrative Health 21.3.8. Bestvite 21.3.9. Vitality Nutritionals 21.3.10. UMZU 21.3.11. NusaPure 21.3.12. Country Life Vitamins 21.3.13. The Vitamin Shoppe 21.3.14. Standard Process 21.3.15. Metabolics 21.3.16. Jarrow Formulas 21.3.17. Solaray 21.3.18. Others (on additional request) 22. Assumptions and Acronyms 23. Research Methodology
Explore Food and Beverage Insights
View Reports
Choline Supplement Market
